{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:07:25Z","timestamp":1793902045660,"version":"4.8.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2500300"],"award-info":[{"award-number":["2021YFC2500300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8227010768"],"award-info":[{"award-number":["8227010768"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800116"],"award-info":[{"award-number":["81800116"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jcyt.2025.03.004","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T15:07:26Z","timestamp":1742224046000},"page":"1124-1129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["CD34-selected stem cell boost was an effective treatment for refractory poor hematopoietic reconstitution after haploidentical hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"27","author":[{"given":"Yun","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1856-2231","authenticated-orcid":false,"given":"Yuqian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jcyt.2025.03.004_bib0001","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1182\/bloodadvances.2018029454","article-title":"Prophylactic oral NAC reduced poor hematopoietic reconstitution by improving endothelial cells after haploidentical transplantation","volume":"3","author":"Kong","year":"2019","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.jcyt.2025.03.004_bib0002","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.transci.2018.04.014","article-title":"Civriz Bozda\u011f S: Graft failure after allogeneic hematopoietic stem cell transplantation","volume":"57","author":"Ozdemir","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"10","key":"10.1016\/j.jcyt.2025.03.004_bib0003","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00277-015-2440-x","article-title":"The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantation","volume":"94","author":"Sun","year":"2015","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1016\/j.jcyt.2025.03.004_bib0004","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.bbmt.2020.03.024","article-title":"Incidence, risk factors, and outcomes of primary prolonged isolated thrombocytopenia after haploidentical hematopoietic stem cell transplant","volume":"26","author":"Tang","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jcyt.2025.03.004_bib0005","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00277-019-03715-w","article-title":"Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days after allogeneic stem cell transplantation","volume":"98","author":"Sun","year":"2019","journal-title":"Ann Hematol"},{"issue":"9","key":"10.1016\/j.jcyt.2025.03.004_bib0006","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.bbmt.2019.05.036","article-title":"Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation","volume":"25","author":"Zhao","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jcyt.2025.03.004_bib0007","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.bbmt.2019.05.013","article-title":"Outcomes of salvage haploidentical transplant with post-transplant cyclophosphamide for rescuing graft failure patients: a report on behalf of the francophone society of bone marrow transplantation and cellular therapy","volume":"25","author":"Prata","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jcyt.2025.03.004_bib0008","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s12185-022-03405-w","article-title":"Outcomes of salvage haploidentical transplantation using posttransplant cyclophosphamide for graft failure following allogeneic hematopoietic stem cell transplantation","volume":"116","author":"Harada","year":"2022","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jcyt.2025.03.004_bib0009","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-024-02276-5","article-title":"Salvage haploidentical transplantation for graft failure after first haploidentical allogeneic stem cell transplantation: an updated experience","author":"Ma","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jcyt.2025.03.004_bib0010","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3727\/096368912X661319","article-title":"Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study","volume":"23","author":"Liu","year":"2014","journal-title":"Cell Transplant"},{"issue":"5","key":"10.1016\/j.jcyt.2025.03.004_bib0011","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1537-2995.2011.03400.x","article-title":"Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation","volume":"52","author":"S\u00e1nchez-Guijo","year":"2012","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.jcyt.2025.03.004_bib0012","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/tme.12300","article-title":"Eltrombopag after allogeneic haematopoietic cell transplantation in a case of poor graft function and systematic review of the literature","volume":"26","author":"Dyba","year":"2016","journal-title":"Transfus Med"},{"issue":"1","key":"10.1016\/j.jcyt.2025.03.004_bib0013","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-018-0649-6","article-title":"Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag","volume":"11","author":"Tang","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"5","key":"10.1016\/j.jcyt.2025.03.004_bib0014","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.bmt.1705760","article-title":"Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation","volume":"40","author":"Jabbour","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jcyt.2025.03.004_bib0015","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ajh.24111","article-title":"Second allogeneic hematopoietic cell transplantation for graft failure: poor outcomes for neutropenic graft failure","volume":"90","author":"Lund","year":"2015","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.jcyt.2025.03.004_bib0016","first-page":"390","article-title":"[Second transplantation for graft failure after allogeneic hematopoietic stem cell transplantation\u2013a retrospective survey by Kanto Study Group for Cell Therapy]","volume":"51","author":"Hagihara","year":"2010","journal-title":"Rinsho Ketsueki"},{"issue":"21","key":"10.1016\/j.jcyt.2025.03.004_bib0017","doi-asserted-by":"crossref","first-page":"30892","DOI":"10.18632\/oncotarget.8810","article-title":"Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants","volume":"7","author":"Kong","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.jcyt.2025.03.004_bib0018","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.seminhematol.2018.08.004","article-title":"Poor graft function after allogeneic hematopoietic stem cell transplantation-an old complication with new insights(\u2606)","volume":"56","author":"Kong","year":"2019","journal-title":"Semin Hematol"},{"issue":"10","key":"10.1016\/j.jcyt.2025.03.004_bib0019","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.bbmt.2013.07.014","article-title":"Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Kong","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jcyt.2025.03.004_bib0020","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1182\/bloodadvances.2021004537","article-title":"Clinical features, pathophysiology, and therapy of poor graft function post-allogeneic stem cell transplantation","volume":"6","author":"Prabahran","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jcyt.2025.03.004_bib0021","doi-asserted-by":"crossref","DOI":"10.1177\/2040620720948743","article-title":"Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation","volume":"11","author":"Chen","year":"2020","journal-title":"Ther Adv Hematol"},{"issue":"11","key":"10.1016\/j.jcyt.2025.03.004_bib0022","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.3324\/haematol.2019.226340","article-title":"Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function","volume":"105","author":"Cuadrado","year":"2020","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.jcyt.2025.03.004_bib0023","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbmt.2017.03.019","article-title":"Fresh or cryopreserved CD34(+)-selected mobilized peripheral blood stem and progenitor cells for the treatment of poor graft function after allogeneic hematopoietic cell transplantation","volume":"23","author":"Ghobadi","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2025.03.004_bib0024","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/bjh.15012","article-title":"CD34(+) selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation","volume":"180","author":"Mainardi","year":"2018","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.jcyt.2025.03.004_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.07.012","article-title":"Outcomes with CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"27","author":"Shahzad","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"9","key":"10.1016\/j.jcyt.2025.03.004_bib0026","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.bbmt.2014.05.016","article-title":"CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation","volume":"20","author":"Stasia","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2025.03.004_bib0027","first-page":"112","article-title":"CD34(+)-selected stem cell \"Boost\" for poor graft function after allogeneic hematopoietic stem cell transplantation","volume":"67","author":"Mohty","year":"2019","journal-title":"Curr Res Transl Med"},{"issue":"12","key":"10.1016\/j.jcyt.2025.03.004_bib0028","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s00432-015-2027-x","article-title":"Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation","volume":"141","author":"Haen","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"10.1016\/j.jcyt.2025.03.004_bib0029","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/bmt.2014.5","article-title":"Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning","volume":"49","author":"Askaa","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2025.03.004_bib0030","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbmt.2013.11.034","article-title":"CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies","volume":"20","author":"Klyuchnikov","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2025.03.004_bib0031","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41409-023-02125-x","article-title":"Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation","volume":"59","author":"Al-Ramahi","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.03.004_bib0032","doi-asserted-by":"crossref","unstructured":"Fraint E, Farooki S, Klein E, Mauguen A, Prockop SE, Scaradavou A, et al. Durable engraftment and excellent overall survival after CD34-selected peripheral blood stem cell boost in pediatric patients with poor graft function following allogeneic stem cell transplantation. Transplant Cell Ther 2023, 29(1):46.e41-46.e46.","DOI":"10.1016\/j.jtct.2022.09.027"},{"key":"10.1016\/j.jcyt.2025.03.004_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101076","article-title":"Belderbos ME: Definitions, incidence and outcome of poor graft function after hematopoietic cell transplantation: a systematic review and meta-analysis","volume":"60","author":"M\u00fcskens","year":"2023","journal-title":"Blood Rev"},{"issue":"8","key":"10.1016\/j.jcyt.2025.03.004_bib0034","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jtct.2021.04.007","volume":"27","author":"Kharfan-Dabaja","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"10.1016\/j.jcyt.2025.03.004_bib0035","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/ajh.25056","article-title":"N-acetyl-L-cysteine improves bone marrow endothelial progenitor cells in prolonged isolated thrombocytopenia patients post allogeneic hematopoietic stem cell transplantation","volume":"93","author":"Kong","year":"2018","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.jcyt.2025.03.004_bib0036","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/bjh.15119","article-title":"N-acetyl-L-cysteine improves mesenchymal stem cell function in prolonged isolated thrombocytopenia post-allotransplant","volume":"180","author":"Kong","year":"2018","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jcyt.2025.03.004_bib0037","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the mount Sinai acute GVHD international consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jcyt.2025.03.004_bib0038","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.03.004_bib0039","article-title":"Graft failure in patients with hematological malignancies: a successful salvage with a second transplantation from a different haploidentical donor","volume":"8","author":"Sun","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"10.1016\/j.jcyt.2025.03.004_bib0040","first-page":"673","article-title":"[Second transplantation for 22 patients with graft failure after first allogeneic stem cell transplantation]","volume":"35","author":"Sun","year":"2014","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"7","key":"10.1016\/j.jcyt.2025.03.004_bib0041","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/s41409-024-02276-5","article-title":"Salvage haploidentical transplantation for graft failure after first haploidentical allogeneic stem cell transplantation: an updated experience","volume":"59","author":"Ma","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jcyt.2025.03.004_bib0042","first-page":"828","article-title":"[Effects of CD34(+) selected stem cells for the treatment of poor graft function after allogeneic stem cell transplantation]","volume":"39","author":"Fei","year":"2018","journal-title":"Zhonghua Xue Ye Xue Za Zhi"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532492500091X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532492500091X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:45:43Z","timestamp":1755618343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S146532492500091X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S146532492500091X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.03.004","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD34-selected stem cell boost was an effective treatment for refractory poor hematopoietic reconstitution after haploidentical hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}